• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of bodywork and movement therapies >Improving the quality of myofascial release research - A critical appraisal of systematic reviews
【24h】

Improving the quality of myofascial release research - A critical appraisal of systematic reviews

机译：提高Myofascial释放研究的质量 - 系统评价的关键评估

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: Myofascial release (MFR) is a form of manual therapy that involves the application of a low load, long duration stretch to the myofascial complex intended to restore optimal length, decrease pain and improve function. MFR is being used to treat patients with a wide variety of conditions, with favourable evidence supporting its efficacy. Critical appraisal of the recent research trials or reviews aims to improve the quality and reliability of future works in this field.Objective: This work attempts to examine and categorize the strength and limitations of current MFR research by critically appraising recent systematic reviews (SRs) to synthesise recommendations for improving quality and reliability of future clinical trials.Methodology: SRs on MFR published until 2018 were selected for this analysis. The methodological qualities of the SRs were assessed by AMSTAR II tool.Results: The SRs demonstrated moderate methodological quality. The overall confidence rating of the results of the review by AMSTAR II was low to moderate, mainly due to the omission of a risk of bias analysis in two of the reviews.Conclusion: This review concludes that the SRs analysed were completed with moderate methodological quality, but with procedural weaknesses and interpretation biases. The most recent review was qualitatively superior due to the inclusion of risk of bias analysis and effect size calculation. This critical appraisal and the derived recommendations can act as 'stepping stones' on which high quality future MFR trials and evidence can be built.
机译：简介：Myofascial释放（MFR）是一种手动治疗的形式，涉及应用低负荷，长持续时间延伸到Myofascial复合物旨在恢复最佳长度，降低疼痛和改善功能。 MFR正在用于治疗患有各种各样的条件的患者，有利于支持其疗效的证据。最近的研究审判或评论的关键评估旨在提高该领域未来作品的质量和可靠性。目的：这项工作试图通过批评最近的系统评价（SRS）来检查和分类当前制造商研究的强度和局限性综合建议提高未来临床试验的质量和可靠性。方法：MFR上的SRS发布于2018年，为此分析选择。通过Amstar II工具评估SRS的方法论质量。结果：SRS表现出中等的方法质量。 Amstar II的审查结果的总体置信度等级低于中度，主要是由于遗漏了两种评论中的偏见分析风险。结论：该综述结论是分析的SRS以中等的方法质量完成。 ，但具有程序弱点和解释偏见。由于包含偏置分析和效果大小计算的风险，最近的评论是定性的。这种关键评估和派生的建议可以充当“踩踏石头”，可以建立高质量的未来MFR试验和证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号